UPDATE: Credit Suisse Reiterates Outperform Rating, Raises PT on Celgene Corporation on Increased Peak Sales Estimates

In a report published Wednesday, Credit Suisse analyst Ravi Mehrotra reiterated an Outperform rating on

, and raised the price target from $113.00 to $125.00. In the report, Credit Suisse noted, “Post this week's PII data for Mongersen (aka GED-0301), we are increasing our peak sales estimates to $3B (from $2B) and concomitantly increasing CELG TP to $125 (from $113).” Celgene Corporation closed on Tuesday at $94.97.